Explore the latest news and updates from Pairidex® as we progress along the path to delivering smarter, faster, and more compassionate blood cancer care.
Jim McCarter, Senior Managing Director of BioGenerator Ventures, sits down with Andrew Young, MD, PhD, of Pairidex and WashU, and Allyson Mayer, PhD, of Pairidex and BioGenerator Ventures. Pairidex is the developer of a droplet digital PCR assay designed to enable accurate detection of gene fusions in blood cancer. Innovators Hour, hosted by BioGenerator, the start-up arm of BioSTL, spotlights...
Paul brings to Pairidex over 20 years of executive leadership experience across the biotech and clinical industries, with a proven track record of driving innovation, scaling organizations, and building high-performing teams. Most recently, he served as CEO at NX Prenatal. Pairidex continues to grow and evolve in developing droplet digital PCR assays designed to enable accurate detection of gene fusions...
Pairidex welcomes Eric Green, M.D., Ph.D., former director of the National Human Genome Research Institute (NHGRI) at the U.S. National Institutes of Health (NIH) from 2009 to 2025 as an Advisor. Dr. Green guided work aimed at improving our understanding of human genetics and using those findings to help develop treatments for genetic diseases. Dr. Green will provide valuable input as...